Current Assets
Trading Securities in Marketable Securities
Boston Scientific Trading Securities in Marketable Securities increased by 38.5% to $396.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $297.00M to $396.00M. Over 5 years (FY 2020 to FY 2025), Trading Securities in Marketable Securities shows an upward trend with a 9.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026
Metric ID:
trading_securities_in_marketable_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $175.00M | $164.00M | $142.00M | $165.00M | $159.00M | $171.00M | $219.00M | $219.00M | $215.00M | $207.00M | $194.00M | $218.00M | $243.00M | $276.00M | $277.00M | $297.00M | $292.00M | $310.00M | $286.00M | $396.00M |
| QoQ Change | — | -6.3% | -13.4% | +16.2% | -3.6% | +7.5% | +28.1% | +0.0% | -1.8% | -3.7% | -6.3% | +12.4% | +11.5% | +13.6% | +0.4% | +7.2% | -1.7% | +6.2% | -7.7% | +38.5% |
| YoY Change | — | — | — | — | -9.1% | +4.3% | +54.2% | +32.7% | +35.2% | +21.1% | -11.4% | -0.5% | +13.0% | +33.3% | +42.8% | +36.2% | +20.2% | +12.3% | +3.2% | +33.3% |
Range$142.00M – $396.00M
CAGR+18.8%
Avg YoY Growth+20.1%
Median YoY Growth+20.6%
Trading Securities in Marketable Securities at Other Companies
Frequently Asked Questions
- What is Boston Scientific's trading securities in marketable securities?
- Boston Scientific (BSX) reported trading securities in marketable securities of $396.00M in Q1 2026.
- How has Boston Scientific's trading securities in marketable securities changed year-over-year?
- Boston Scientific's trading securities in marketable securities increased by 33.3% year-over-year, from $297.00M to $396.00M.
- What is the long-term trend for Boston Scientific's trading securities in marketable securities?
- Over 5 years (2020 to 2025), Boston Scientific's trading securities in marketable securities has grown at a 9.3% compound annual growth rate (CAGR), from $183.00M to $286.00M.